Erectile dysfunction: Topical gel gets FDA nod for over-the-counter marketing

Futura Medical has developed Eroxon, a topical gel for erectile dysfunction, which has been authorized for over-the-counter marketing in the US. The product, already available in Belgium and the UK, is the first of its kind available without a prescription.
Futura Medical has developed Eroxon, a topical gel for erectile dysfunction, which has been authorized for over-the-counter marketing in the US. The product, already available in Belgium and the UK, is the first of its kind available without a prescription.

FDA grants OTC marketing clearance to topical gel for erectile

Imiquimod Cream

Futura's pioneering research receives FDA approval - Platinum

Selective Capture and Recovery of Monoclonal Antibodies by Self

Gels, Free Full-Text

Eroxon, First Over-The-Counter Erectile Dysfunction Gel, Gets FDA

The US FDA OTC Approval of Topical Gel for Erectile Dysfunction

Haleon nabs rights to Futura's OTC erectile dysfunction gel

First Non-Prescription Erectile Dysfunction Gel Gets FDA Okay

FDA OKs Over-the-Counter Gel for Erectile Dysfunction

Eroxon, First Over-The-Counter Erectile Dysfunction Gel, Gets FDA

First Non-Prescription Erectile Dysfunction Gel Gets FDA Okay